Ekansh Mittal – Page 92 – Katalyst Wealth

21st Aug’20 – Jun’20 earnings update on Chaman Lal and Suven Pharma

August 21, 2020

Dear Members, We have released 21st Aug’20 – Jun’20 earnings update on Chaman Lal Setia and Suven Pharmaceuticals. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 21st Aug’20 Chaman Lal Setia (BSE – 530307) – Sep’19 Alpha stock CMP – 99.85 (BSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Chaman Lal has reported good set of numbers for the quarter ending…

Model Portfolio – Completion of 2 Years and the Performance Card

August 16, 2020

Dear Members, Hope you all are doing well. We have completed 2 years of Model Sheet service and would like to share with you our Performance card. The Model Sheet service was started on 15th Aug’18 and the purpose of the same was 2-fold: Determine performance of our stock research on Portfolio basis (against benchmark indices) than on individual stocks basis Give an easily replicable (from any point onwards) sheet to members so that they can make the most of…

[Report]: Delisting Opportunity – Low Downside and Expecting Promoters to buy out at much higher price

August 12, 2020

Dear Sir, Hope you are doing good and taking proper precautions. As you might be aware, besides investing in stocks of good companies for long term wealth creation, another smarter way of making money in stock markets is to participate in Special situation opportunities (SSOs). Have also benefited from this strategy with several Special Situation opportunities like Ineos Styrosolution delisting, Suven life-Suven Pharma demerger, Linde India delisting, Hexaware delisting, etc appreciating by 20-140% in a period of 2-11 months. SSOs are relatively shorter term (3-4 months) opportunities and…

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20 Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…